Cigna Corp. (CI) Tops Q4 EPS by 9c, Revenues Beat; Offers FY19 EPS Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
After-Hours Movers 1/31: (SYMC) (DGII) (CY) Higher; (CVS) (CI) (AMZN) (more...)
January 31, 2019 5:49 PM ESTToday's After-Hours Movers
Symantec (NASDAQ: SYMC) 6.3% HIGHER; reported Q3 EPS of $0.44, $0.05 better than the analyst estimate of $0.39. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.18 billion. Symantec sees Q4 2019 EPS of $0.37-$0.41, versus the consensus of $0.38. Symantec sees Q4 2019 revenue of $1.19-1.22 billion, versus the consensus of $1.21 billion. Symantec sees FY2019 EPS of $1.57-$1.61, versus the consensus of $1.54. Symantec sees FY2019 revenue of $4.76-4.79 billion, versus the consensus of $4.74 billion.
Trump Administration Proposes to Lower Drug Costs by Targeting Backdoor Rebates and Encouraging Direct Discounts to Patients
January 31, 2019 4:38 PM ESTOn Thursday, Health and Human Services Secretary Alex Azar and Inspector General Daniel Levinson proposed a rule to lower prescription drug prices and out-of-pocket costs by encouraging manufacturers to pass discounts directly on to patients and bringing new transparency to prescription drug markets.
Every day, Americansparticularly our seniorspay more than they need to for their prescription drugs because of a hidden system of kickbacks to middlemen. President Trump is proposing to end this era of backdoor deals in the drug industry, bring real transparency to drug markets, and deliver savings directly to patients when they walk into... More
